Mostrar el registro sencillo del ítem
dc.contributor.author | Arias Vallejo, Francisco Javier | |
dc.contributor.author | Santos García, María Mercedes | |
dc.contributor.author | Ibáñez Fonseca, Arturo | |
dc.contributor.author | Piña, María Jesús | |
dc.contributor.author | Serrano Dúcar, Sofía | |
dc.date.accessioned | 2017-04-03T10:44:08Z | |
dc.date.available | 2017-04-03T10:44:08Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Current Drug Targets, 2016, vol. 17, pages 1-20 | es |
dc.identifier.issn | 1389-4501 | es |
dc.identifier.uri | http://uvadoc.uva.es/handle/10324/22951 | |
dc.description.abstract | Drug delivery systems that are able to control the release of bioactive molecules and designed to carry drugs to target sites are of particular interest for tissue therapy. Moreover, systems comprising materials that can respond to environmental stimuli and promote self-assembly and higher order supramolecular organization are especially useful in the biomedical field. Suitable biomaterials for this purpose include elastin-like recombinamers (ELRs), a class of proteinaceous polymers bioinspired by natural elastin and designed usingrecombinant technologies. The self-assembly and thermoresponsive behaviour of these systems, along with their biodegradability, biocompatibility and well-defined composition as a result of their tailor-made design, make them particularly attractive for drug delivery. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Bentham Science | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.subject.classification | Elastin-like Recombinamers | es |
dc.subject.classification | Drug delivery | es |
dc.subject.classification | Smart systems | es |
dc.subject.classification | Self-Assembly | es |
dc.subject.classification | Hydrogels | es |
dc.subject.classification | Nanocarriers | es |
dc.title | Elastin-like recombinamers as smart drug delivery systems | es |
dc.type | info:eu-repo/semantics/article | es |
dc.identifier.doi | 10.2174/1389450117666160201114617 | es |
dc.peerreviewed | SI | es |
dc.description.project | Este trabajo forma parte de Proyectos de Investigación financiados por la Comisión Europea a través del Fondo Social Europeo (FSE) y el Fondo Europeo de Desarrollo Regional (ERDF), por el del MINECO (MAT2013-41723R, MAT2013-42473-R, MAT2012-38043 y PRI-PIBAR-2011-1403), la Junta de Castilla y León (VA049A11, VA152A12 y VA155A12) y el Instituto de Salud Carlos III bajo el Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León. | es |